Edward L. Erickson has been named president and chief executive officer of Cholestech Corp...United Biomedical is focused on developing diagnostics and vaccines for AIDS, hepatitis C, HTLV and other infectious diseases

Celgene (NASDAQ:CELG) of Warren, N.J., is developing fine and specialty chemicals and proprietary hazardous waste biotreatment systems...Warren was previously vice president of finance and administration at Itek Graphix Composition Systems of AB Dick...The Cambridge, Mass., company (NASDAQ:GENZ) develops novel therapeutic proteins and biomaterials

David W. Ortlieb and Richard R. Pivirotto have been nominated to the board of Immunomedics Inc...Ortlieb is president and chief executive officer of Texas Biotechnology Corp...Jensen was founding partner and chairman of Woodbury, Jensen, Kesler & Swinton, a Salt Lake City law firm

O'Neill was executive vice president and chairman of international operations for Warner-Lambert Co...Alex McPherson has been appointed president and chief executive officer of Biomira Inc...Parkinson was vice president for clinical development and regulatory affairs at Liposome Technology Inc. (c) 1997 American Health Consultants

has elected Richard K. Donahue, president and chief operating officer of Nike Inc., to its board...Gwynne was director of scientific affairs and manager of exploratory projects at Allelix Biopharmaceuticals Inc...of San Diego are Dr. Stanley Crooke, Ph.D., chairman and chief executive officer of Isis Pharmaceuticals Inc., and Gavin S. Herbert, chairman and CEO of Allergan Inc

Sullivan is the former chairman, president and chief executive officer of Burroughs Wellcome Co...Athena Neurosciences focuses on diagnostics and therapeutics for central nervous system diseases and disorders. (c) 1997 American Health Consultants

George W. Ebright will remain chairman and chief executive officer...MacTaggart recently retired as chairman and president of Pfizer International...SIBIA is developing diagnostic and therapeutic products for neurodegenerative conditions. ///BIOWORLD ..DATE920504 NO.001 Ref: BioWorld, 05/4/92, Vol. 4 No

Argus develops new drugs and drug carrier systems for the treatment of cancer and serious infections...Smith was previously president and chief executive officer at Applied Biosystems Inc

Kung and Goldstein developed OKT3 while working at Johnson & Johnson's Ortho Pharmaceutical Corp...in 1984 and is its chief scientific officer and vice chairman of the board. (c) 1997 American Health Consultants

Capizzi had been director of the Comprehensive Cancer Center and chairman of the Piedmont Oncology Association at the Bowman Gray School of Medicine, both of Wake Forest University, and chief of the section on hematology/oncology...Erickson is currently professor of chemistry and co-director of the protein chemistry laboratory at the University of North Carolina, Chapel Hill

Robison will lead efforts to develop and commercialize diagnostic tests for human immunodeficiency virus (HIV-1) antibodies in urine and saliva...and E. Andrews Grinstead III, chairman and chief executive officer of Genesis Inc

Tropix develops, manufactures and markets chemiluminescent reagents and related products...supplies chemicals and instruments for biotechnology and health care applications. (c) 1997 American Health Consultants

Gorder will be responsible for clinical and regulatory affairs and will serve on the executive committee...He is president and chief executive officer of Scripps Clinic and Research Foundation

Gelb had been president and CEO of Landec Labs Inc...David Corbet remains president and chief operating officer of Diagnostics, which develops products for monitoring immune system disorders...Gustav A. Christensen, formerly president and chief executive officer of ImmuLogic Pharmaceutical Corp., has been named chairman of Alpha-Beta Technology, a Worchester, Mass., developer of carbohydrate-based health care products

Philippe Lacaille, formerly vice president and general manager of Pharmacia AB, has been appointed executive vice president and chief operating officer of IAF BioChem International Inc. (NASDAQ:BCHXF), a Laval, Quebec, developer of vaccines, therapeutics and diagnostic products...Kazuhiro Hashimoto, director of research and development and a member of the board of Zenyaku Kogyo Co

Magee will now supervise clinical and regulatory affairs as well as R&D. James T. Ryaby, formerly a graduate research associate at Mount Sinai School of Medicine, will become director of research...Steven S. Cowell has resigned as vice president and controller of Cetus...to become vice president and chief financial officer of Agouron Pharmaceuticals Inc. (NASDAQ: AGPH), a La Jolla, Calif

Jack Vaughn and Michael Viguerie have been named to the board at Imre Corp. (NASDAQ:IMRE), a Seattle developer and producer of technology for treating blood outside the body...and Cashavelly was previously a product manager at Bristol-Myers Squibb Co

Barry W. Steiger has joined MGI Pharma Inc. (NASDAQ: MOGN), a Minneapolis developer and marketer of pharmaceuticals, as vice president of medical affairs...Bannister, formerly of the corporate and financial relations group for Regis McKenna Inc., will be responsible for investor, media and community relations

Brown had been a financial consultant to clients in manufacturing and distribution in the toy, government contracting and wholesale wine and spirits industry. (c) 1997 American Health Consultants